[1]
molica, matteo 2024. Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy: Long-lasting disease remission with third line therapy with gilteritinib. Mediterranean Journal of Hematology and Infectious Diseases. 16, 1 (Oct. 2024), e2024079. DOI:https://doi.org/10.4084/MJHID.2024.079.